SAN FRANCISCO, Oct. 10 – Hyseq and Deltagen will collaborate in a project to analyze proteins for drug targets, the companies announced Wednesday.

Sunnyvale, Calif.-based Hyseq will supply about 200 secreted protein gene sequences for Redwood City-based Deltagen to analyze via mammalian gene knockout technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.